Publications | Lund University Publications

1 – 8 of 8

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Lassila%2C+R.%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Lassila%2C+R.%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2016
Mark Inhibitor development in previously untreated patients with severe haemophilia A : a nationwide multicentre study in Finland
Vepsäläinen, K. ; Lassila, R. ; Arola, M. ; Huttunen, P. ; Koskinen, S. ; Ljung, R. ^LU ; Lähteenmäki, P. ; Möttönen, M. and Riikonen, P. (2016) In Haemophilia 22(5). p.721-729
- Contribution to journal › Article
2014
Mark Managing Haemophilia for Life: 4th Haemophilia Global Summit
Astermark, Jan ^LU ; Dolan, G. ; Hilberg, T. ; Jimenez-Yuste, V. ; Laffan, M. ; Lassila, R. ; Lobet, S. ; Martinoli, C. and Perno, C. -F. (2014) In Haemophilia 20. p.1-20
- Contribution to journal › Scientific review
2012
Mark von Willebrand's disease: a report from a meeting in the Åland islands.
Berntorp, Erik ^LU ; Peake, I ; Budde, U ; Laffan, M ; Montgomery, R ; Windyga, J ; Goodeve, A ; Petrini, A B ; von Depka, M and Miesbach, W , et al. (2012) In Haemophilia 18 Suppl 6. p.1-13
- Contribution to journal › Article
2011
Mark The pro-FEIBA study: prophylactic dosing of Factor Eight Inhibitor Bypassing Activity (FEIBA) reduces bleeding frequency in haemophilia a patients with inhibitors
Gringeri, A. ; Antmen, B. ; Berntorp, Erik ^LU ; Biasioli, C. ; Carpenter, S. ; Kavakli, K. ; Lassila, R. ; Morfini, M. ; Negrier, C. and Rocino, A. , et al. (2011) In Haemophilia 17(2). p.23-23
- Contribution to journal › Published meeting abstract
2010
Mark A prospective, randomized, and crossover study of an activated prothrombin complex concentrate for secondary prophylaxis in patients with hemophilia A and inhibitors (Pro-FEIBA): subject demographics and safety data
Leissinger, C. ; Negrier, C. ; Berntorp, Erik ^LU ; Windyga, J. ; Serban, M. ; Bulent, A. ; Lassila, R. ; Kavakli, K. ; Zulfikar, B. and Gringeri, A. (2010) XXIXth International Congress of the World Federation of Hemophilia In Haemophilia 16(Suppl. 4). p.31-31
- Contribution to journal › Published meeting abstract
Mark FEIBA prophylaxis in haemophilia patients: a clinical update and treatment recommendations
Perry, D. ; Berntorp, Erik ^LU ; Tait, C. ; Dolan, G. ; Holme, P. A. ; Laffan, M. ; Lassila, R. ; Mumford, A. ; Pasi, J. and Wilde, J. , et al. (2010) In Haemophilia 16(1). p.80-89
- Contribution to journal › Article
2008
Mark Natural anticoagulation and endothelial markers in association with allogeneic stem cell transplantation and graft-versus-host disease
Pinomaki, A ; Volin, L ; Joutsi-Korhonen, L ; Strandberg, Karin ^LU ; Hillarp, Andreas ^LU ; Ruutu, T and Lassila, R (2008) EBMT 2008 In Bone Marrow Transplantation 41(Suppl. 1). p.62-63
- Contribution to journal › Published meeting abstract
Mark European principles of haemophilia care
Colvin, B. T. ; Astermark, Jan ^LU ; Fischer, K. ; Gringeri, A. ; Lassila, R. ; Schramm, W. ; Thomas, A. and Ingerslev, J. (2008) In Haemophilia 14(2). p.361-374
- Contribution to journal › Article